Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|August 1, 2008
Are Your Patients Washing Their Hands of Medication?
Tell patients not to wash their hands after they apply medication to treat scabies or lice.
Advertisement
Tell patients not to wash their hands after they apply medication to treat scabies or lice. When patients scratch, parasites may become lodged under their fingernails. Hand washing removes the medication from under the fingernails, allowing any parasites there to remain alive and spread infection.
-- Richard Honaker, MD
Carrollton, Tex
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Advertisement
Advertisement
Trending on Patient Care Online
1
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
2
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
3
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
4
Why Real-World Evidence Matters for Nonhormonal Menopause VMS Therapy
5